tiprankstipranks
Trending News
More News >
Omnicell (OMCL)
NASDAQ:OMCL
US Market

Omnicell (OMCL) Earnings Dates, Call Summary & Reports

Compare
346 Followers

Earnings Data

Report Date
May 13, 2026
After Close (Confirmed)
Period Ending
2026 (Q1)
Consensus EPS Forecast
0.33
Last Year’s EPS
0.26
Same Quarter Last Year
Based on 7 Analysts Ratings

Earnings Call Summary

Q4 2025
Earnings Call Date:Feb 05, 2026|
% Change Since:
|
Earnings Call Sentiment|Positive
The call presents a cautiously optimistic outlook: Omnicell reported revenue and ARR growth, exceeded guidance midpoints for bookings and revenue, and launched strategic products (Titan XT, Omnisphere) with encouraging customer response and a stronger pipeline. However, the company faces margin pressure (tariffs and mix), lower GAAP/non-GAAP per-share results in the quarter and year, a meaningful cash balance reduction due to debt repayment and buybacks, and some service/retail segment headwinds. Management frames the adverse items as strategic investments (product launch, financing options, ERP transformation and go-to-market investments) that position the company for multi-year growth and higher recurring revenue, and 2026 guidance reflects modest top-line and EBITDA expansion while factoring in tariff and ERP costs. On balance, the positive operational momentum and guidance modestly outweigh the financial headwinds, but execution on margin recovery and conversion to Titan/Omnisphere will be critical.
Company Guidance
Omnicell guided Q1 2026 total revenue of $300–$310M (product $171–176M; service $129–134M), with Q1 non‑GAAP EBITDA of $27–33M and non‑GAAP EPS of $0.26–0.36 (noting seasonally higher payroll/tax costs). For full‑year 2026 it forecast product bookings of $510–560M, total revenue of $1.215–1.255B (product $690–710M; service $525–545M), year‑end ARR of $680–700M, non‑GAAP EBITDA of $145–160M and non‑GAAP EPS of $1.65–1.85. Management’s guidance incorporates an estimated ~$15M of tariff costs hitting the P&L in 2026, an estimated non‑GAAP effective tax rate of ~13%, and about $10M of ERP implementation costs in 2026, and reflects an expected ~2x EBITDA expansion versus revenue growth while incremental Omnisphere software revenue is expected to materialize beginning in 2027.
Annual Recurring Revenue (ARR) Growth
Exited 2025 with ARR of $636M, up 10% from the 2024 exit rate; 2026 year-end ARR guidance of $680M–$700M (projected ~7%–10% growth vs. 2025 exit).
Full-Year Revenue Growth and Guidance
Full year 2025 total revenue was $1.185B (up from $1.112B in 2024, roughly +6.6%) and 2026 revenue guidance of $1.215B–$1.255B reflects continued growth.
Bookings and Backlog Performance
Full-year 2025 product bookings of $535M landed above the midpoint of guidance; product backlog exited 2025 at $640M (down ~1% year-over-year) with $435M short-term backlog expected to convert in 2026.
Product & Platform Innovation Momentum
Launched Titan XT and advanced Omnisphere (achieved high-trust CSF I one certification); positive early customer feedback from ASHP and notable wins (large health systems, VA, Canadian providers). Management reports a strengthened top-of-funnel and competitive traction.
Service Revenue Strength
Full year 2025 service revenue was $519M (up from $482M in 2024, +7.7%); Q4 2025 service revenue $134M, up 8% YoY — contributing to recurring revenue expansion.
Product Revenue Growth (Full Year)
Full year 2025 product revenue was $666M versus $631M in 2024, an increase of ~5.6% year-over-year, driven by connected device demand (XT family).
Profitability Run-Rate and 2026 Profit Guidance
Non-GAAP EBITDA for full year 2025 was $140M (up from $136M in 2024, +2.9%). 2026 non-GAAP EBITDA guidance of $145M–$160M signals continued expansion, and non-GAAP EPS guidance of $1.65–$1.85 indicates modest improvement potential.
Operational Improvements and Receivables
Days Sales Outstanding improved to 65 days in 2025 from 77 days in 2024, indicating better collections and working capital management.

Omnicell (OMCL) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

OMCL Earnings History

Report Date
Fiscal Quarter
Forecast / EPS
Last Year's EPS
EPS YoY Change
Press Release
Slides
Play Transcript
May 13, 2026
2026 (Q1)
0.33 / -
0.26
Feb 05, 2026
2025 (Q4)
0.50 / 0.40
0.6-33.33% (-0.20)
Oct 30, 2025
2025 (Q3)
0.36 / 0.51
0.56-8.93% (-0.05)
Jul 31, 2025
2025 (Q2)
0.27 / 0.45
0.51-11.76% (-0.06)
May 06, 2025
2025 (Q1)
0.20 / 0.26
0.03766.67% (+0.23)
Feb 06, 2025
2024 (Q4)
0.58 / 0.60
0.3381.82% (+0.27)
Oct 30, 2024
2024 (Q3)
0.42 / 0.56
0.62-9.68% (-0.06)
Aug 01, 2024
2024 (Q2)
0.14 / 0.51
0.57-10.53% (-0.06)
May 02, 2024
2024 (Q1)
-0.09 / 0.03
0.39-92.31% (-0.36)
Feb 08, 2024
2023 (Q4)
0.15 / 0.33
0.330.00% (0.00)
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed

OMCL Earnings-Related Price Changes

Report Date
Price 1 Day Before
Price 1 Day After
Percentage Change
Feb 05, 2026
$46.69$39.08-16.30%
Oct 30, 2025
$29.57$33.58+13.56%
Jul 31, 2025
$29.70$31.01+4.41%
May 06, 2025
$30.49$25.66-15.84%
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.

FAQ

When does Omnicell (OMCL) report earnings?
Omnicell (OMCL) is schdueled to report earning on May 13, 2026, After Close (Confirmed).
    What is Omnicell (OMCL) earnings time?
    Omnicell (OMCL) earnings time is at May 13, 2026, After Close (Confirmed).
      Where can I see when companies are reporting earnings?
      You can see which companies are reporting today on our designated earnings calendar.
        What companies are reporting earnings today?
        You can see a list of the companies which are reporting today on TipRanks earnings calendar.
          What is OMCL EPS forecast?
          OMCL EPS forecast for the fiscal quarter 2026 (Q1) is 0.33.